Virasoft is at USCAP 2024 and inviting you to Booth #1049, 4 poster and 1 platform sessions with Virasoft AI-powered decision support products and co-authored.
Virasoft's research article titled "Tubule-U-Net: a novel dataset and deep learning-based tubule segmentation framework in whole slide images of breast cancer" is available in the Scientific Reports of Nature from 2023.
Virasoft's new centralized viewer is now integrated with all Virasoft workflow solutions.
In conclusion of 2023, Virasoft co-founder and co-CEO Samet Ayalti reflects on Virasoft's key moments and achievements throughout the year.
The PathoClass platform functions as an online educational tool, enabling members of İstinye University School of Medicine to effortlessly organize virtual digital pathology courses with efficiency.
Since 2020, Virasoft has been organizing a monthly webinar series of neuropathology coordinated by Tarik Tihan, MD, PhD, and the Turkish Neuropathology Working Group of the Turkish Pathology Federation.
Virasoft deploys its image management and AI solutions at the Yilmaz Laboratory at the Koch Institute for Integrative Cancer Research at MIT.
Virasoft launched a project to build a machine learning model for breast cancer diagnosis featuring oncological treatment methodologies.
Virasoft is now ISO 13485 – Quality Management System certified.
Virasoft is proud to announce that once again entitled to the ISO27001 - Information Security Management System certificate.
Virasoft is pleased to announced that they will be a part of the USCAP Annual conference in Los Angeles as a Gold Level Sponsor.
International Hospital Group, Acibadem, own more than 20 hospitals all around Turkey where Virasoft provides digital pathology systems that optimize the pathology workflow with digital slide management.
Ankara City Hospital Pathology, brand-new hospital in the capital of Turkey, equipped with state-of-the-art technology, harbors 3704 beds and 65 pathologists where digital pathology is provided by Virasoft.
Fluorescence in situ hybridization (FISH) approach is constituted of a pair of complementary techniques for precisely detecting...
Fluorescence in situ hybridization (FISH) is a technique that prepares acceptable results for molecular imaging biomarkers to...
Pathologists conduct a biopsy on a tissue when a carcinoma case for a patient is suspected. They stain the cells on that tissue...
HER2 is recognized as an essential prognostic parameter in breast cancer.
For more information about our solutions, you can contact us and request a demo.
Once we receive your form, we will contact you for appropriate demo dates.
You can contact us by filling out the form below.